Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMJGleeson Regulatory News (GLE)

Share Price Information for MJGleeson (GLE)

Share Price is delayed by 15 minutes
Get Live Data
230.00    0.00 (0.00%)
Bid:
221.00
Ask:
0.00
Spread: 9.00 (4.072%)
Market Cap: £134.17m
GLE Live PriceLast checked at - London Stock Exchange

Intraday MJGleeson Share Chart

Holding(s) in Company

20 Jun 2011 13:44

RNS Number : 7464I
Gleeson(M J)Group PLC
20 June 2011
 

 

 

TR-1: Notifications of Major Interests in Shares

 

 

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:

 

M J Gleeson Group Plc

 

2. Reason for notification (yes/no)

 

An acquisition or disposal of voting rights

 

Yes

 

An acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

 

An event changing the breakdown of voting rights

 

Other (please specify):______________

 

3. Full name of person(s) subject to notification obligation:

 

North Atlantic Value LLP (as investment advisor/manager)

 

4. Full name of shareholder(s) (if different from 3):

1. North Atlantic Smaller Companies Investment Trust PLC

 

2. Oryx International Growth Fund Limited

 

3. North Atlantic Value LLP (as investment manager/adviser to other fund management clients)

 

5. Date of transaction (and date on which the threshold is crossed or reached if different):

 

17 June 2011

 

6. Date on which issuer notified:

 

20 June 2011

 

7. Threshold(s) that is/are crossed or reached:

 

Through 21% and individual holding through 6%

 

8: Notified Details

A: Voting rights attached to shares

 

Class/type of shares

If possible use ISIN code

Situation previous to the triggering transaction

Resulting situation after the triggering transaction

Number of shares

Number of voting rights

Number of shares

Number of voting rights

Percentage of voting rights

 

Direct

 

Indirect

 

Direct

 

Indirect

 

Ordinary Shares

Sedol: B01BNK2

 

Holder 1 7,095,976 7,095,976 7,259,639 7,259,639 13.78%  

 

Holder 2 3,171,917 3,171,917 3,316,576 3,316,576 6.29%

 

Holder 3 505,000 505,000 505,000 505,000 0.96%

 

Total voting rights = 21.03%

 

B: Financial Instruments

 

Resulting situation after the triggering transaction

 

Type of financial instrument

Expiration date

Exercise/ conversion period/date

No. of voting rights that may be acquired (if the instrument exercised/converted)

Percentage of voting rights

 

 

 

 

Total (A+B)

 

Number of voting rights

Percentage of voting rights

 

 

11,081,215

 

 

21.03%

 

9. Chain of controlled undertakings through which the voting rights and /or the financial instruments are effectively held, if applicable:

 

Proxy Voting:

 

10. Name of proxy holder:

 

11. Number of voting rights proxy holder will cease to hold:

 

12. Date on which proxy holder will cease to hold voting rights:

 

 

13. Additional information:

 

North Atlantic Value LLP is the investment manager/advisor in respect of the full 21.03% holding as it is investment manager/adviser to holders 1 and 2 as well as the other private clients included in holder 3.

14 Contact name:

 

Bonita Guntrip - Client Company Secretary, J O Hambro Capital Management Limited

 

15. Contact telephone number:

 

020 7747 5681

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLFMMTTMBITBTB
Date   Source Headline
9th Jun 20262:17 pmRNSDirector/PDMR Shareholding
9th Jun 20267:00 amRNSUpdate on Gleeson Land
2nd Jun 20267:00 amRNSBoard Committee Changes
7th May 20264:36 pmRNSDirector/PDMR Shareholding
7th May 20262:49 pmRNSDirector/PDMR Shareholding
1st May 20267:00 amRNSTrading Update
23rd Apr 20267:00 amRNSNotice of Trading Updates and FY2026 Results
14th Apr 20269:34 amRNSDirector/PDMR Shareholding
14th Apr 20269:33 amRNSDirector/PDMR Shareholding
6th Mar 20263:19 pmRNSDirector/PDMR Shareholding
2nd Mar 20264:04 pmRNSHolding(s) in Company
11th Feb 20267:00 amRNSResults for the half year ended 31 December 2025
9th Feb 202610:47 amRNSDirector/PDMR Shareholding
9th Feb 20267:00 amRNS-RPresentation of HY Results on Engage Investor
16th Jan 20267:00 amRNSTrading Update and Notice of Results
6th Jan 20264:40 pmRNSDirector/PDMR Shareholding
9th Dec 202511:31 amRNSDirector/PDMR Shareholding
25th Nov 20251:01 pmRNSDirector/PDMR Shareholding
20th Nov 20253:25 pmRNSHolding(s) in Company
14th Nov 20252:46 pmRNSResult of AGM
14th Nov 20257:01 amRNSAppointment of Non-Executive Director
14th Nov 20257:00 amRNSAGM Trading Update
6th Nov 20255:09 pmRNSDirector/PDMR Shareholding
24th Oct 20254:16 pmRNSDirector/PDMR Shareholding
23rd Oct 20255:07 pmRNSDirector/PDMR Shareholding
20th Oct 20254:09 pmRNSDirector/PDMR Shareholding
17th Oct 20257:00 amRNSNotice of AGM
7th Oct 20253:18 pmRNSDirector/PDMR Shareholding
22nd Sep 20255:01 pmRNSREPLACEMENT: Director/PDMR Shareholding
18th Sep 20257:00 amRNS-RPresentation on Engage Investor Platform
17th Sep 20254:23 pmRNSDirector/PDMR Shareholding
16th Sep 20257:00 amRNSAudited results for the year ended 30 June 2025
9th Sep 202510:45 amRNSDirector/PDMR Shareholding
13th Aug 20257:00 amRNSNotice of Full-Year Results and Presentation
7th Aug 20253:05 pmRNSDirector/PDMR Shareholding
10th Jul 20254:17 pmRNSDirector/PDMR Shareholding
9th Jul 20251:05 pmRNSHolding(s) in Company
8th Jul 20254:00 pmRNSDirector/PDMR Shareholding
7th Jul 20253:11 pmRNSHolding(s) in Company
4th Jul 20257:00 amRNSDirectorate Change
4th Jul 20257:00 amRNSTrading Statement
12th Jun 20253:21 pmRNSDirector/PDMR Shareholding
10th Jun 202511:34 amRNSDirector/PDMR Shareholding
6th Jun 20257:00 amRNSHolding(s) in Company
4th Jun 20255:06 pmRNSDirector/PDMR Shareholding
3rd Jun 20257:03 amRNSTrading Update
7th May 20252:33 pmRNSDirector/PDMR Shareholding
24th Apr 20257:00 amRNSDirectorate Change
8th Apr 20255:22 pmRNSDirector/PDMR Shareholding
8th Apr 20255:17 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.